Brief: Nordic Nanovector To Amend PARADIGME Trial Protocol

Thor Medical ASA

30/06/2020 06:05

June 30 (Reuters) - Nordic Nanovector ASA  NANOV.OL :
    * NORDIC NANOVECTOR TO AMEND PARADIGME TRIAL PROTOCOL TO
EXPAND
ELIGIBLE PATIENT POPULATION
    * WILL AMEND TRIAL PROTOCOL FOR ITS PARADIGME TRIAL TO
BROADEN
INCLUSION CRITERIA AND EXPAND POOL OF ELIGIBLE PATIENTS WITH AIM
OF INCREASING PRESENT RATE OF ENROLMENT

Source text for Eikon:  ID:nWkrc3y9c2 
Further company coverage:  NANOV.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))